Abstract
Over the last 10 years rapid advances in molecular biology have led to a much greater understanding of several important cardiac disorders. It is likely that over the next ten years great advances in management of these patients will occur as a result of further advances in molecular medicine. The moleculoar genetic basis of hypertrophic cardiomyopathy and some forms of dilated cardiomyopathy are known, as well as long QT syndrome and Marfans syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference List
Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne, Guicheney P, Hainque B, Bouhour JB, et al. Penetrance of familial hypertrophic cardiomyopathy. Genet.Couns. 1997;8(2):107–14.
Landing BH, Recalde AL, Lawrence TK, Shankle WR. Cardiomyopathy in childhood and adult life, with emphasis on hypertrophic cardiomyopathy. Pathol. Res. Pract. 1994;190(8):737–49.
Ryan MP, Cleland JF, French JA, Joshi J, Choudhury L, Chojnowska L, Michalak E, Al-Mahdawi S, Nihoyannopoulos P, Oakley CM. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am.J.Cardiol. 1995;76(10):689–94.
Solomon SD, Wolff S, Watkins H, Ridker PM, Come P, McKenna WJ. Seidman, CE, Lee RT. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J.Am.Coll.Cardiol. 1993;22(2):498–505.
Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopat. N. Engl. J. Med. 1995; 332(16):1058–64.
Anan R, Greve G, Thierfelder L, Watkins H, McKenna WJ, Solomon S, Vecchio C, Shono H, Nakao S, Tanaka H, et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopath. J.Clin.Invest. 1994;93(l):280–5.
Yu B, French JA, Jeremy RW, French P, McTaggart DR, Nicholson MR, Semsarian C, Richmond DR, Trent RJ. Counselling issues in familial hypertrophic cardiomyopathy. J Med Genetic 1998;35(3): 183–8.
Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J.Clin.Invest. 1995;95(3): 1409–14.
Golitsina N, An Y, Greenfield NJ, Thierfelder L, Iizuka K, Seidman JG, Seidman CE, Lehrer SS, Hitchcock-DeGregori SE. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function. Biochemistry 1997;36(15):4637–42.
Yoneya K, Okamoto H, Machida M, Onozuka H, Noguchi M, Mikami T, Kawaguchi H, Murakami M, Uede T, Kitabatake A. Angiotensin-Converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am.Heart J. 1995; 130(5): 1089–93.
Geisterfer-Lowrance AT, Kass S, Tanigawa G, Vosberg H-P, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell 1990;62(5):999–1006.
Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg, Seidman JG, Seidman CE. Alpha-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcome. Cell 1994;77(5):701–12.
Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat.Genet 1995; 11(4):434–7.
Kimura A, Harada H, Park J-E, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat.Genet. 1997;16(4):379–82.
MacRae CA, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins HC, Anan,, Thierfelder LH, McGarry K, Rowland E, et al. Familial hypertrophie cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J.Clin.Invest. 1995;96(3): 1216–20.
Shibata M, Yamakado T, Imanaka-Yoshida K, Isaka N, Nakano T. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome progressing to ventricular dilation. Am.Heart J. 1996; 131(6): 1223–5.
Muntoni F, Di Lenarda A, Porcu M, Sinagra G, Mateddu A, Marrosu G, Ferlini A, Cau M, Milasin J, Melis MA, et al. Dystrophin gene abnormalities in two patients with idiopathic dilated cardioyopathy. Heart 1997;78(6):608–12.
Towbin JA. The role of cytoskeletal proteins in cardiomyopathies. Current Opin Cell Biol 1998;10(l):131–9.
Olson TM, Keating MT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 1996;97(2):528–32.
Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker IIP, Cody RJ, Fishman MC, et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome lpl-lql. Nature Genetics 1994;7(4): 546–51.
Durand J-B, Bachinski LL, Bieling LC, Czernuszewicz GZ, Abchee AB, Qun TY, Tapscott T, Hill R, Ifegwu J, Marian AJ, et al. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome lq32. Circulation 1995;92(12):3387–9.
Krajinovic M, Pinamonti B, Sinagra G, Vatta M, Severini GM, Milasin J, Falaschi A, Camerini F, Giacca M, Mestroni L, et al. Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Gen 1995;57(4):846–52.
Bowles KR, Gajarski R, Porter P, Goytia V, Bachinski L, Roberts R, Pignatelli R, Towbin JA. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest 1996;98(6): 1355–60.
Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. J.Am.Coll.Cardiol. 1997;30(6): 1512–20.
Marcus FI, Fontaine G. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review. Pacing Clin.Electrophysiol. 1995; 18(6): 1298–314.
McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br.Heart J. 1994;71(3):215–8.
Nava A, Canciani B, Thiene G, Scognamiglio R, Buja G, Martini B, Daliento L, Fasoli G, Stritoni P, Dalla VS. Analysis of the mode of transmission of right ventricular dysplasia. Arch.Mal.Coeur Vaiss. 1990;83(7):923–8.
Coonar A, Protonotarios N, Tsatsopoulou A, Needham S, Houlston R, Cliff S, Otter M, Murday V, Mattu R, McKenna WJ. Gene for Arrhythmogenic Right Ventricular Cardiomyopathy with diffuse nonepidermolytic palmoplanar keratoderma and woolly hair (Naxos Disease) maps to 17q21. Circulation 1998;97(20):2049
Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum.Mol.Genet. 1994;3(6):959–62.
Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Danieli GA. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum.Mol.Genet. 1995;4(11):2151–4.
Rampazzo A, Nava A, Miorin M, Fonderico P, Pope B, Tiso N, Livolsi B, Zimbello R, Thiene G, Danieli GA. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 1997;45(2):259–63.
Severini GM, Krajinovic M, Pinamonti B, Sinagra G, Fioretti P, Brunazzi, MC, Falaschi A, Camerini F, Giacca M, et al. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 1996;31(2): 193–200.
Tomita Y, Iijima M. Romano-Ward syndrome. Ryoikibetsu Shokogun Shirizu 1996;(12):211–4.
Aoki T. Jervell and Lange-Nielsen syndrome. Ryoikibetsu Shokogun Shirizu 1996;(12):188–91.
Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, Grancini F, Marni E, Perticone F, Rosti D, et al. Prolongation of the QT Interval and the Sudden Infant Death Syndrome. N.Engl.J.Med 1998;338(24): 1709–14.
Ackerman MJ. The long QT syndrome: Ion channel diseases of the heart. Mayo Clinic Proceedings 1998;73(3):250–69.
Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80(5):805–11.
Satler CA, Walsh EP, Vesely MR, Plummer MH, Ginsburg GS, Jacob HJ. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome. Am.J.Med Genet. 1996;65(l):27–35.
Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat.Genet. 1997; 15(2): 186–9.
Duggal P, Vesely MR, Wattanasirichaigoon D, Villafane J, Kaushik V, Beggs AH. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 1998;97(2): 142–6.
Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, Chivoret G, Schwartz K, Coumel P, Guicheney P. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997;96(9):2778–81.
Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80(5):795–803.
Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92(10):2929–34.
Priori SG, Napolitano C, Cantu F, Brown AM, Schwartz PJ. Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ.Res. 1996;78(6):1009–15.
Keene DR, Jordan CD, Reinhardt DP, Ridgway CC, Ono RN, Corson GM, Fairhurst M, Sussman MD, Memoli VA, Sakai LY. Fibrillin-1 in human cartilage: developmental expression and formation of special banded fibers. J.Histochem.Cytochem. 1997;45(8): 1069–82.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Norman, M.W., D’Cruz, L.G., Mahon, N., McKenna, W.J. (2000). Cardiovascular Molecular Genetics. In: Osterhues, HH., Hombach, V., Moss, A.J. (eds) Advances in Noninvasive Electrocardiographic Monitoring Techniques. Developments in Cardiovascular Medicine, vol 229. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4090-4_1
Download citation
DOI: https://doi.org/10.1007/978-94-011-4090-4_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5796-7
Online ISBN: 978-94-011-4090-4
eBook Packages: Springer Book Archive